Our data indicate that systemic interference with Cdc7/Cdk9 activity results in a strong suppression of the adaptive immune response and likely affects not only the adaptive response to tumors but also the ability of the immune system to react to cancer-associated opportunistic infections (26). The gene discussed is CDK9; the disease is cancer.